Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;39(5):836-846.
doi: 10.1002/mds.29763. Epub 2024 Mar 13.

Longitudinal Free-Water Changes in Dementia with Lewy Bodies

Affiliations

Longitudinal Free-Water Changes in Dementia with Lewy Bodies

Shannon Y Chiu et al. Mov Disord. 2024 May.

Abstract

Background: Diffusion-weighted magnetic resonance imaging (dMRI) examines tissue microstructure integrity in vivo. Prior dementia with Lewy bodies (DLB) diffusion tensor imaging studies yielded mixed results.

Objective: We employed free-water (FW) imaging to assess DLB progression and correlate with clinical decline in DLB.

Methods: Baseline and follow-up MRIs were obtained at 12 and/or 24 months for 27 individuals with DLB or mild cognitive impairment with Lewy bodies (MCI-LB). FW was analyzed using the Mayo Clinic Adult Lifespan Template. Primary outcomes were FW differences between baseline and 12 or 24 months. To compare FW change longitudinally, we included 20 cognitively unimpaired individuals from the Alzheimer's Disease Neuroimaging Initiative.

Results: We followed 23 participants to 12 months and 16 participants to 24 months. Both groups had worsening in Montreal Cognitive Assessment (MoCA) and Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores. We found significant FW increases at both time points compared to baseline in the insula, amygdala, posterior cingulum, parahippocampal, entorhinal, supramarginal, fusiform, retrosplenial, and Rolandic operculum regions. At 24 months, we found more widespread microstructural changes in regions implicated in visuospatial processing, motor, and cholinergic functions. Between-group analyses (DLB vs. controls) confirmed significant FW changes over 24 months in most of these regions. FW changes were associated with longitudinal worsening of MDS-UPDRS and MoCA scores.

Conclusions: FW increased in gray and white matter regions in DLB, likely due to neurodegenerative pathology associated with disease progression. FW change was associated with clinical decline. The findings support dMRI as a promising tool to track disease progression in DLB. © 2024 International Parkinson and Movement Disorder Society.

Keywords: Lewy body disease; dementia with Lewy bodies; diffusion‐weighted imaging; magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

S.Y. Chiu receives research support from NIH (K23 AG073525-01A1). R. Chen has no relevant disclosures. W. Wang has no relevant disclosures. M.J. Armstrong receives research support from the NIH (R01AG068128, P30AG047266, R01NS121099, R44AG062072), the Florida Department of Health (grant 20A08), and as the local PI of a Lewy Body Dementia Association Research Center of Excellence. She serves on the DSMBs for the Alzheimer’s Therapeutic Research Institute/Alzheimer’s Clinical Trial Consortium and the Alzheimer’s Disease Cooperative Study. She has provided educational content for Medscape, Vindico CME, and Prime Inc. B.F. Boeve receives honorarium for SAB activities for the Tau Consortium, institutional research grant support from the Lewy Body Dementia Association, American Brain Foundation, Alector, Biogen, Transposon, and GE Healthcare. R. Savica receives support from the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Parkinson’s Disease Foundation, and Acadia Pharmaceuticals. V. Ramanan receives research support from NIH. J.A. Fields receives research support from NIH. N. Graff-Radford receives research support as the local PI of a Lewy Body Dementia Association Research Center of Excellence and from NIH. T.J. Ferman receives research support from NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, and Ted Turner and Family LBD Functional Genomics Program. K. Kantarci receives research support from NIH, Avid Radiopharmaceuticals, Eli Lilly and consults for Biogen. D.E. Vaillancourt receives research support from NIH and is Co-Founder of Automated Imaging Diagnostics.

Figures

Figure 1
Figure 1
A-L: Regions of interest (ROIs) in DLB/MCI-LB with significant increase in FW from baseline to 12-(blue) and 24-months (orange). For each significant ROI, the corresponding plot on the left shows mean FW changes for each follow-up time-point with standard error bars; and the corresponding plot on the right shows FW changes for each participant from baseline to 12- and 24-months.
Figure 2.
Figure 2.
T1-structural MRI (axial) showing larger network of ROIs in DLB/MCI-LB identified with significant FW increases at 24-months (3D paired t test for baseline to 24-months, right), compared to 12-months (3D paired t test for baseline to-12 months, left). Overlay is displaying the mean difference in FW at p<0.001 (uncorrected). The coordinate system is in MNI space (with a left posterior inferior orientation). Consistent longitudinal FW increases at both time-points were seen in amygdala, posterior cingulum, entorhinal cortex, parahippocampus, insula, fusiform, retrosplenial cortex, rolandic operculum, and supramarginal gyrus regions. At 24-months, additional FW increases were seen in the pallidum, putamen, mid cingulum, hippocampus, inferior frontal, superior temporal, and thalamus regions.

Similar articles

Cited by

References

    1. Savica R, Boeve BF, Logroscino G. Epidemiology of alpha-synucleinopathies: from Parkinson disease to dementia with Lewy bodies. Handb Clin Neurol. 2016;138:153–8. - PubMed
    1. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017. Jul 4;89(1):88–100. - PMC - PubMed
    1. McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020. Apr 28;94(17):743–55. - PMC - PubMed
    1. Ferman TJ, Smith GE, Kantarci K, Boeve BF, Pankratz VS, Dickson DW, et al. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013. Dec 3;81(23):2032–8. - PMC - PubMed
    1. Kantarci K, Lesnick T, Ferman TJ, Przybelski SA, Boeve BF, Smith GE, et al. Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment. Neurology. 2016. Nov 29;87(22):2317–23. - PMC - PubMed

MeSH terms